Translational Virology in Pregnancy

Translational virology: The process of creating new information and scientific evidence for healthcare requirements is known as translational virology. As with the creation of COVID-19 drugs and vaccines, governmental organisations and authorities have a significant influence on this process. Basic, preclinical, and clinical research, drug production, and drug regulation and approval are the several subfields of translational virology.

Translational virology in pregnancy: Pregnant women's health and the health of their unborn children are being adversely affected by more frequent viral pandemics like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Depending on the virus, infection during pregnancy may increase the risk of more serious prenatal sickness, preterm birth, preeclampsia, stillbirth, and/or a long-term increase in the risk of neuropsychiatric disorder in the children.

To understand the effects of viral infections during pregnancy on the foetus, usually starts with in vitro and in vivo models, concentrating on the placental reaction to infection
Some of the viruses that associated with pregnancy are:

• Ebola virus
• Hepatitis B virus (HBV)
• Hepatitis C virus (HCV)
• Hepatitis E virus (HEV)
• Human immunodeficiency virus (HIV)
• Zika virus
• SARS-COV-2